Literature DB >> 8196513

Phenotypic change in portal fibroblasts in biliary fibrosis.

L Tang1, Y Tanaka, F Marumo, C Sato.   

Abstract

Portal fibroblasts have been considered responsible for biliary fibrosis. Since lipocytes show differentiation toward myofibroblast-like cells in hepatic fibrogenesis, we studied whether similar differentiation of portal fibroblasts could be observed in biliary fibrosis. We examined rat livers after bile duct ligation by double immunofluorescent staining of alpha-smooth-muscle actin (alpha-smA) and desmin and also by electronmicroscopy. In the portal tract of normal livers, alpha-smA-positive cells were noted only in the vessel wall, whereas desmin-positive cells were occasionally seen in the connective tissue as well. With the development of biliary fibrosis, alpha-smA was remarkably expressed in the portal connective tissue, while desmin was seen in a small portion of alpha-smA-positive cells around proliferating bile ducts. In normal livers, portal fibroblasts presented quiescent features, such as a small Golgi complex and a few cisternal profiles of endoplasmic reticulum under electron microscopy. After 7 days of bile duct ligation, portal fibroblasts proliferated, were arrayed in multilayers, and were associated with collagen bundles. Some of these fibroblasts had numerous cytoskeletal components, and developed rough endoplasmic reticulum and a dense body. These data suggest that portal fibroblasts appear to differentiate toward myofibroblasts in biliary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196513     DOI: 10.1111/j.1600-0676.1994.tb00051.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  18 in total

Review 1.  Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

Authors:  A-J Demetris; John-G Lunz; Susan Specht; Isao Nozaki
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

2.  Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction.

Authors:  J K Olynyk; G C Yeoh; G A Ramm; S L Clarke; P M Hall; R S Britton; B R Bacon; T F Tracy
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 3.  The origin of fibrogenic myofibroblasts in fibrotic liver.

Authors:  Tatiana Kisseleva
Journal:  Hepatology       Date:  2017-01-11       Impact factor: 17.425

4.  Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.

Authors:  Abby L Olsen; Bridget K Sackey; Cezary Marcinkiewicz; David Boettiger; Rebecca G Wells
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

Review 5.  Mechanisms of liver fibrosis and its role in liver cancer.

Authors:  Debanjan Dhar; Jacopo Baglieri; Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-10

6.  Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts.

Authors:  Xiao Liu; Jun Xu; David A Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2013-09

7.  Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis.

Authors:  W W Tang; T R Ulich; D L Lacey; D C Hill; M Qi; S A Kaufman; G Y Van; J E Tarpley; J S Yee
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 8.  Cellular sources of extracellular matrix in hepatic fibrosis.

Authors:  Rebecca G Wells
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

9.  Role of alphavbeta6 integrin in acute biliary fibrosis.

Authors:  Bruce Wang; Brian M Dolinski; Noriko Kikuchi; Diane R Leone; Marion G Peters; Paul H Weinreb; Shelia M Violette; D Montgomery Bissell
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

10.  Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver.

Authors:  Julien Villeneuve; Fanny Pelluard-Nehme; Chantal Combe; Dominique Carles; Christine Chaponnier; Jean Ripoche; Charles Balabaud; Paulette Bioulac-Sage; Sébastien Lepreux
Journal:  Comp Hepatol       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.